ESIC labelled certain batch of Voglibose 0.2 mg as “Not of standard Quality”

May 28, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe Employees State Insurance Corporation (ESIC) on May 24, 2023, issued a notification to label the Voglibose Tab/Cap - Each Tab/Cap to contain: Voglibose 0.2 mg as “Not of standard Quality”

The following has been stated namely: -

• Directed to immediately stop the use of the batch which has been reported as "Not of Standard Quality”

• It is also directed the action may be taken as per the clause for ‘Testing of Drugs-Quality’ of Terms & Conditions of respective DG-ESIC RC. Replacement of supplies or cost of the material is to be recovered along with testing charges, if any, from the firm

• The Table with the RC No./Item No./Page No., Batch No., etc. has been inserted in the notification.

 

[Notification No. U-25/12/NSQ/2023-Med V (E - 178406)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT